Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular Therapies | Zendy

Anthony R. Mato | Zendy; Lindsey E. Roeker | Zendy; Toby A. Eyre | Zendy; Ryan Jacobs | Zendy; Brian T. Hill | Zendy; Nicole Lamanna | Zendy; Danielle M. Brander | Zendy; Mazyar Shadman | Zendy; Chaitra S. Ujjani | Zendy; Maryam Sarraf Yazdy | Zendy; Guilherme Fleury Perini | Zendy; Javier Pinilla Ibarz | Zendy; Jacqueline C. Barrientos | Zendy; Alan P Skarbnik | Zendy; Pallawi Torka | Zendy; Jeffrey J. Pu | Zendy; John M. Pagel | Zendy; Satyen H. Gohil | Zendy; Bita Fakhri | Zendy; Michael Y. Choi | Zendy; Catherine C. Coombs | Zendy; Joanna Rhodes | Zendy; Paul M. Barr | Zendy; Craig A. Portell | Zendy; Helen Parry | Zendy; Christine Garcia | Zendy; Kate J. Whitaker | Zendy; Allison Winter | Zendy; Andrea Sitlinger | Zendy; Sirin Khajavian | Zendy; Ariel GrajalesCruz | Zendy; Krista M. Isaac | Zendy; Pratik Shah | Zendy; Othman Salim Akhtar | Zendy; Rachael Pocock | Zendy; Kentson Lam | Zendy; Timothy Voorhees | Zendy; Stephen J. Schuster | Zendy; Thomas D. Rodgers | Zendy; Nicolás MartínezCalle | Zendy; Talha Munir | Zendy; Erica B. Bhavsar | Zendy; Neil A. Bailey | Zendy; Jason C. Lee | Zendy; Hanna Weissbrot | Zendy; Chadi Nabhan | Zendy; Julie M. Goodfriend | Zendy; Amber C. King | Zendy; Andrew D. Zelenetz | Zendy; Colleen Dorsey | Zendy; Kayla Bigelow | Zendy; Bruce D. Cheson | Zendy; Christopher P. Fox | Zendy; John N. Allan | Zendy

Open Access

Efficacy of Therapies Following Venetoclax Discontinuation in CLL: Focus on B-Cell Receptor Signal Transduction Inhibitors and Cellular Therapies

Author(s) -

Anthony R. Mato,

Lindsey E. Roeker,

Toby A. Eyre,

Ryan Jacobs,

Brian T. Hill,

Nicole Lamanna,

Danielle M. Brander,

Mazyar Shadman,

Chaitra S. Ujjani,

Maryam Sarraf Yazdy,

Guilherme Fleury Perini,

Javier Pinilla Ibarz,

Jacqueline C. Barrientos,

Alan P Skarbnik,

Pallawi Torka,

Jeffrey J. Pu,

John M. Pagel,

Satyen H. Gohil,

Bita Fakhri,

Michael Y. Choi,

Catherine C. Coombs,

Joanna Rhodes,

Paul M. Barr,

Craig A. Portell,

Helen Parry,

Christine Garcia,

Kate J. Whitaker,

Allison Winter,

Andrea Sitlinger,

Sirin Khajavian,

Ariel GrajalesCruz,

Krista M. Isaac,

Pratik Shah,

Othman Salim Akhtar,

Rachael Pocock,

Kentson Lam,

Timothy Voorhees,

Stephen J. Schuster,

Thomas D. Rodgers,

Nicolás MartínezCalle,

Talha Munir,

Erica B. Bhavsar,

Neil A. Bailey,

Jason C. Lee,

Hanna Weissbrot,

Chadi Nabhan,

Julie M. Goodfriend,

Amber C. King,

Andrew D. Zelenetz,

Colleen Dorsey,

Kayla Bigelow,

Bruce D. Cheson,

Christopher P. Fox,

John N. Allan

Publication year - 2019

Publication title -

blood

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.515

H-Index - 465

eISSN - 1528-0020

pISSN - 0006-4971

DOI - 10.1182/blood-2019-123747

Subject(s) - venetoclax , medicine , signal transduction , discontinuation , alemtuzumab , cancer research , immunology , oncology , chronic lymphocytic leukemia , leukemia , biology , antibody , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom

About

About Careers Publisher Partners Contact Us Get Organisational Trial or Quote

Learn

FAQs Blog Terms of Use Privacy Policy

Download the Zendy App

Address

About

Learn

Download the Zendy App

Discover

Explore